GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (XMAD:GRF) » Definitions » 3-Year Dividend Growth Rate
中文

Grifols (XMAD:GRF) 3-Year Dividend Growth Rate

: 0.00% (As of Dec. 2023)
View and export this data going back to 2006. Start your Free Trial

Grifols's Dividends per Share for the three months ended in Dec. 2023 was €0.00.

The historical rank and industry rank for Grifols's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Grifols was 46.30% per year. The lowest was -20.00% per year. And the median was 9.75% per year.

XMAD:GRF's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.7
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Grifols's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Grifols's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols 3-Year Dividend Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Grifols's 3-Year Dividend Growth Rate falls into.



Grifols 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Grifols  (XMAD:GRF) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Grifols's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ Earnings per Share (Diluted) (Q: Dec. 2023 )
=0/ 0.082
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Grifols was 1.20. The lowest was 0.20. And the median was 0.38.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Grifols was 3.42%. The lowest was 0.48%. And the median was 1.28%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grifols 3-Year Dividend Growth Rate Related Terms>


Grifols (XMAD:GRF) Business Description

Industry
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.